Brean Capital Sees Tremendous Growth Opportunities In LDR Holding

In a report written by Brean Capital analyst Jason Wittes, LDR Holding Corp LDRH was initiated with a Buy rating and a $50 one-year price target.

Wittes wrote, "Given the degree of differentiation and the potential for LDRH's cervical disc technology to disrupt the current cervical fusion market, we think this is a unique company with a significantly better growth profile than its small- to mid-cap peers."

LDR Holding has developed two highly differentiated technology platforms. The first is Mobi-C, a cervical disc backed by five years of clinical data. The second is VerteBridge, which is used in spinal fusion and is less invasive than its competitor's products. Because of these technologies, Brean Capital said that the company has the potential to be the fastest-growing publicly traded spine company.

LDR Holding released earnings on February 18, reporting revenue of $39.50 million and EPS of ($0.12) beating the consensus estimates of $36.40 million and ($0.16), respectively.

LDR Holding recently traded at $38.53, up 2.2 percent.